News
FDA Approves IDE for Mercy’s Ovarian Cancer Screening Test
The FDA IDE approval allows Mercy BioAnalytics to initiate a prospective clinical study to evaluate the safety of the ovarian cancer screening test in average-risk women, following Institutional Review Board (IRB) approval.


